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First Case of Spondylodiscitis Caused by 
Actinobaculum schaalii, a Rare Pathogen 
Causing Urinary Tract Infection in the Elderly 
P. Haller*, T. Bruderer, S. Schaeren, G. Laifer, 
R. Frei, M. Battegay, U. Fl~ickiger, S. Bassetti. 
Division o[ In[ectious Diseases and Hospital 
Epiderniology, University Hospital Basel, Basel, 
Switzerland 
Background: Actinobaculurn schaalii (AS) is a fac- 
ultatively anaerobic Gram-positive rod bacterium, 
first described in 1997. Of 13 patients with AS infec- 
tion reported so far, 11 had urinary tract infection 
and 11 were older than 63 years. 
Objectives: We describe the first case of spondy- 
lodiscitis caused by AS, and review all patients at 
our institution with an AS isolate between 1/02 and 
12/05. 
Methods: Since 1/02 all relevant bacterial isolates 
not identified by standard biochemical methods 
have been identified by 16S rDNA sequencing. All 
bacteria growing in specimens supposed to be ster- 
ile, and monocultures from unsterile sites were 
considered relevant. 
Results: During the observation period we iden- 
tified 5 patients with AS isolates. All 5 patients 
were elderly (mean 85.4 years), 2 had underly- 
ing genitourinary tract pathology. Four had urinary 
tract infections; the 5th patient had spondylodisci- 
tis with AS bacteremia. This 71-year old male pa- 
tient presented with immobilising low back pain, 
no fever and a CRP of 55mg/l. The initial CT 
scan showed no signs of the clinically suspected 
spondylodiscitis. As the low-back pain persisted 
2 weeks after admission, MRI of the lumbar spine 
was performed showing spondylodiscitis at L3/L4. 
The cultures of the CT-guided biopsy yielded mod- 
erate amounts of AS and Eorynebacteriurn stria- 
turn. AS was also isolated from the blood cultures 
drawn on the same day. Since only AS was found in 
the blood cultures (1 of four bottles), we assumed 
it to be more virulent than E. striaturn and to be 
the causative agent. The empirical treatment with 
vancomycin was changed to amoxicillin/clavulanic 
acid 3x2.2g/day iv, when the susceptibility data 
were available. During the 8 weeks of iv treatment 
the low back pain improved and the patient was 
mobilized with a soft brace. Ten months later he 
showed a nearly complete recovery with only mild 
stress-dependent low back pain. Radiologically the 
spondylodiscitis was healed. 
Conclusion: Finding 5 patients with AS infec- 
tions during the 48 months after implementa- 
tion of 16S rDNA sequencing indicates that this 
pathogen is not as rare as assumed, and suggests 
that AS is rather under diagnosed. Our case with 
spondylodiscitis supports the hypothesis that AS 
does not only cause urinary tract infections, but 
also bacteremia with septic complications. Besides 
older age, underlying enitourinary tract pathology 
(10 of 18 reported patients) predisposes to infec- 
tion with this pathogen. 
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Zygomycosis in Neonates: A Systematic Review 
of Reported Cases 
E. Roilides*, T.E. Zaoutis, M.M. Roden, 
W.L. Buchanan, T.A. Knudsen, T.A. Sarkisova, 
R.L. Schaufele, M. Sein, T. Sein, C.C. Chiou, 
R Prasad, J.H. Chu, T.J. Walsh. Aristotle 
University, Thessaloniki, Greece 
Background: Zygornycosis has merged as an in- 
creasingly important infection with a high mor- 
tality especially in immunocompromised pediatric 
patients. No comprehensive analysis of neonatal 
zygornycosis cases has been punished to date. 
Objective: To systematically review and analyze 
reported cases of neonatal zygornycosis. 
Methods: PUBMED search for English publications 
of neonatal (0-30 days) zygomycosis cases and 
references from major books as well as single case 
reports or case series. Individual references were 
reviewed for additional cases. Data were collected 
in Filemaker-Pro database. Evaluation of differ- 
ences was performed by Fisher Exact test. 
Results: 33 cases (61% male) were found with me- 
dian age 14.6 days (IQR 7.3, 18.3). The predomi- 
nant underlying condition was prematurity (70%); 
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whereas, other risk factors, such as diabetes met- 
titus, neutropenia, corticosteroid therapy, and iron 
toad, previously reported in older patients were 
virtually non-existent. No apparent underlying con- 
dition was found in 4 neonates (12%). The most 
common patterns of zygomycosis were dissem- 
inated (49%), gastrointestinal (24%), deeply ex- 
tended (15%) and cutaneous (6%) disease. 15 (45%) 
cases were diagnosed by histology only and 18 (55%) 
by histology and culture. Among 18 culture- 
confirmed cases, Rhizopus pp. were isolated from 
14 (78%) cases with mortality of 50%. Among 12 pa- 
tients who were given antifunga[ therapy, 7 re- 
ceived an amphotericin B formulation only, white 5 
received an amphotericin B formulation combined 
with other antifunga[ agents. However, 21 patients 
received no antifunga[ therapy. Overall mortal- 
ity was 26/33 (79%) as compared to 56.4% for 
children >30d and 52.8% for adults (CID 41:634, 
2005; p < 0.02). Mortality was not significantly re- 
lated with decade of publication, gender or race. 
Mortality was tower (2/7 or 29%) among patients 
who received an amphotericin B formulation than 
among neonates who received no antifunga[ ther- 
apy (21/21 or 100%, p=0.0002); 16 (48%) neonates 
underwent surgery. With exception of two cuta- 
neous cases that were both cured, at[ other pat- 
terns of zygomycosis carried a mortality rate ~>83%. 
Conclusions: Zygomycosis an extremely serious 
infection in neonates with a high mortality and 
strong propensity to disseminate. Amphotericin B 
formulations ignificantly improve outcome. 
10 
Parvovirus B19 and Nlyocarditis in an Infant 
C. Hassib*, N. Sekarski, R Mey[an, R Roux- 
Lombard, B. Vaudaux. Centre Hospitalier 
Universitaire Vaudois, Lausanne, Suisse 
Background: Parvovirus B19 (PV B19) infection can 
cause a wide spectrum of disease syndromes. It is 
emerging as a new and important candidate for my- 
ocarditis and subsequent dilated cardiomyopathy 
(DCM) in immunocompetent and immunocompro- 
raised children. 
The mechanism of PV B19 induced post natal my- 
ocarditis and subsequent DCM is different from that 
in other viral myocarditides and is characterized by 
infection of intracardiac endothelial celts of small 
arterioles and veinu[es, with endothelial dysfunc- 
tion, impairment of myocardial microcircu[ation, 
penetretion of inflammatory celts and eventually 
myocyte necrosis. Recent data suggest that the 
cytokines interferon-gamma, tumor necrosis factor 
alpha and inter[eukin-6 and -8, wich are observed 
at high levels in PV B19-associated myocarditis in 
children in addition to microcircu[atory dysfunc- 
tion, contribute to myocardial damage and inflam- 
mation. 
We report a case of life-threatening PV B19 DCM 
secondary to PV B19 myocarditis in immunocom- 
petent toddler. The aim of this paper is to alert 
clinicians to the rote of PV B19 in infant myocarditis 
and DCM. 
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Lipopolysaccharide (LPS)Induced Priming 
of Human Newborn Polymorphonuclear 
Neutrophils (PMN) is Diminished due to 
Decreased Levels of MyD88 and Attenuated 
p38 Phosphorylation 
W. A[-Hertani, S.R. Yan, D. Byers, R. Borto[ussi* 
Dalhousie University, Halifax, Nova Scotia, Canada 
Background: Diminished response of po[ymor- 
phonuc[ear neutrophi[s (PMN) to [ipopo[ysaccharide 
(LPS) has been implicated in the increased sus- 
ceptibility of human newborns to Gram-negative 
bacteria[ infections. LPS activates or primes PMN 
for a variety of host defense functions including 
enhanced production of oxidative radicals (respi- 
ratory burst), a process that is known to involve 
the Mitogen-Activated Protein (MAP) kinase p38. 
Objectives: To determine the celt signaling path- 
ways that may contribute to the attenuation of 
priming for newborn PMN. 
Methods: PMN were isolated from newborn um- 
bilical cord and adult blood. PMN [ysates were 
separated on SDS PAGE and probed for MAP ki- 
nases, Toil-like Receptor-4 (TLR-4), Mye[oid Differ- 
entiation Factor 88 (MyD88) using Western blotting. 
Functional activation was assayed after stimulation 
with LPS using flow cytometry to determine CD66b 
upregu[ation as an indicator of degranu[ation. 
Results: We found that p38 phosphory[ation i
newborn PMN is attenuated in response to LPS 
stimulation even though adult and newborn PMN 
have similar amounts of p38 protein. The degree 
of attenuation in newborn PMN was dependent on 
the osmo[arity of the medium. In addition, LPS- 
induced degranu[ation, a process that is p38 de- 
pendent, was also absent in newborn PMN. We also 
assessed LPS receptors on PMN and observed that 
white TLR-4 is present at similar levels on newborn 
and adult PMN, its downstream adaptor protein 
MyD88 was significantly diminished in newborn PMN 
compared to adult celts. 
Conclusion: Although the mechanism of PMN prim- 
ing by LPS is not fully understood, our results 
suggest hat MyD88 and p38 phosphory[ation are 
